PI 3-kinase: a pivotal pathway in T-cell activation?
Ward
S G
SG
Dept. of Pharmacology, School of Pharmacy and Pharmacology, University of Bath, Claverton Down, UK. prpsgw@bath.ac.uk
June
C H
CH
Olive
D
D
D000730:Androstadienes / Q000494:pharmacology; D018106:CD28 Antigens / Q000502:physiology; D015704:CD4 Antigens / Q000502:physiology; D002470:Cell Survival; D006801:Humans; D008213:Lymphocyte Activation; D019869:Phosphatidylinositol 3-Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000502:physiology*; D011493:Protein Kinase C / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D011948:Receptors, Antigen, T-Cell / Q000502:physiology; D019893:Ribosomal Protein S6 Kinases; D013601:T-Lymphocytes / Q000276:immunology*; D000077191:Wortmannin
D000730:Androstadienes; D018106:CD28 Antigens; D015704:CD4 Antigens; D019869:Phosphatidylinositol 3-Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor); D011493:Protein Kinase C; D017346:Protein Serine-Threonine Kinases; D011948:Receptors, Antigen, T-Cell; D019893:Ribosomal Protein S6 Kinases; D000077191:Wortmannin